WallStreetZenWallStreetZen

NASDAQ: TBPH
Theravance Biopharma Inc Stock Ownership - Who owns Theravance Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Theravance Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rick E. WinninghamCHIEF EXECUTIVE OFFICER2025-08-2015,394$13.39
$206.13kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2025-08-209,096$13.39
$121.80kSell
Brett A. GrimaudSVP GEN COUNSEL AND SECRETARY2025-08-209,762$13.39
$130.71kSell
Aine MillerSVP DEV HEAD OF IRE OFFICE2025-08-206,989$13.39
$93.58kSell
Aziz SawafSVP CHIEF FINANCIAL OFFICER2025-08-209,368$13.39
$125.44kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2025-07-144,000$11.39
$45.55kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2025-07-14682$11.39
$7.77kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2025-07-145,318$11.39
$60.55kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2025-06-0224,000$11.00
$264.00kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2025-05-209,120$9.45
$86.18kSell

1 of 3

TBPH insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TBPH insiders and whales buy or sell their stock.

TBPH Shareholders

What type of owners hold Theravance Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eli Samaha35.79%18,022,500$265.83MInsider
Glaxosmithkline PLC19.15%9,644,807$142.26MInsider
Madison Avenue Partners LP18.89%9,511,150$140.29MInstitution
Weiss Asset Management LP14.81%7,457,060$109.99MInstitution
Weiss Asset Management LP14.81%7,457,060$109.99MInsider
Newtyn Management LLC9.83%4,950,000$73.01MInstitution
Blackrock Inc8.22%4,139,025$61.05MInstitution
Irenic Capital Management LP5.48%2,760,948$40.72MInstitution
Vanguard Group Inc4.28%2,157,430$31.82MInstitution
Rick E. Winningham3.62%1,823,853$26.90MInsider

1 of 3

TBPH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TBPH51.78%48.22%Net SellingNet Selling
MBX37.95%62.05%Net BuyingNet Buying
VIR67.90%32.10%Net SellingNet Selling
CRMD50.35%10.12%Net SellingNet Buying
GLUE34.03%65.97%Net Buying
View Top Biotech Stocks

Theravance Biopharma Stock Ownership FAQ

Who owns Theravance Biopharma?

Theravance Biopharma (NASDAQ: TBPH) is owned by 92.21% institutional shareholders, 85.86% Theravance Biopharma insiders, and 0.00% retail investors. Eli Samaha is the largest individual Theravance Biopharma shareholder, owning 18.02M shares representing 35.79% of the company. Eli Samaha's Theravance Biopharma shares are currently valued at $269.44M.

If you're new to stock investing, here's how to buy Theravance Biopharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.